Goodwin Procter LLP advised ANA Therapeutics on the deal. ANA Therapeutics announced its sale to NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO). ANA is a biotechnology company developing…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
